A Comparison of INSORB Staples With Metal Staples in Total Hip Replacement

NCT ID: NCT00940446

Last Updated: 2018-01-30

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2010-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the use of INSORB absorbable staples with metal staples on surgical incision healing after total hip replacement. The study evaluates wound healing, complications, and patient satisfaction regarding wound comfort and appearance after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subcuticular closure of wounds can provide superior results to percutaneous suture closure due to the elimination of suture or staple tracts. These tracts can lead to infection and migration of epithelial cells adding to scarring, and cross-hatching scars which remain after healing. Absorbable staples can provide a rapid, secure, subcuticular closure of skin as an alternative to the traditional, manual staple or suture closure. This study will compare INSORB absorbable staples to externally applied standard metal staples with respect to effectiveness of incision closure, acute healing, subject comfort level, security and appearance after total hip replacement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Erythema Drainage Bruising Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Insorb staples

Subcuticular Absorbable staples

Group Type EXPERIMENTAL

Insorb staples

Intervention Type DEVICE

absorbable staples required for wound closure

Control

Metal staple wound closure

Group Type ACTIVE_COMPARATOR

metal staples (Ethicon metal stapler)

Intervention Type DEVICE

wound closure with metal staples

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insorb staples

absorbable staples required for wound closure

Intervention Type DEVICE

metal staples (Ethicon metal stapler)

wound closure with metal staples

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Insorb absorbable stapler GDW Ethicon metal stapler

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is 18 years or older
* Patient or legal representative is able to understand and provide signed consent for the procedure
* Patient is willing and able to return for required follow-up visits
* Patient needs a total hip arthroplasty surgical procedure

Exclusion Criteria

* Patient has an active infection
* Patient is enrolled in another similar study
* Patient has a known history of hepatitis
* Patient has a known history of HIV
* Patient has a known history of AIDs
* Patient has a known history of IV drug abuse
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

OrthoIndy

OTHER

Sponsor Role collaborator

Orthopaedic Research Foundation

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David A Fisher, MD

Role: PRINCIPAL_INVESTIGATOR

Indiana Orthopaedic Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Indiana Orthopaedic Hospital

Indianapolis, Indiana, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DAF_PC000001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HIP-STITCH (Wound Recovery After THA)
NCT06275776 RECRUITING NA
Dual Mobility in "High Risk" Patients
NCT04092634 ACTIVE_NOT_RECRUITING PHASE4
Hip DAA Closure Techniques
NCT06006572 UNKNOWN NA